Products Liability Law Daily Mercedes-Benz recalls 104K vehicles for software update
News
Friday, December 7, 2018

Mercedes-Benz recalls 104K vehicles for software update

By Colleen Kave, J.D.

Mercedes-Benz USA, LLC (MBUSA) has recalled around 104,663 2018 C300 Cabriolet, C300 Coupe, C300 4Matic Cabriolet, C300, C300 4Matic Coupe, C300 4Matic, C43 AMG Cabriolet, C43 AMG Coupe, C63 S AMG Cabriolet, C350e Plug-In Hybrid, C63 AMG Cabriolet, C63 AMG Coupe, C63 S AMG Coupe, C63 AMG, C63 S AMG, 2018-2019 GLC300 4Matic Coupe, GLC300, GLC63 AMG Coupe, GLC300 4Matic, GLC350e Plug-In Hybrid, GLC43 AMG Coupe, GLC43 AMG, GLC63 S AMG Coupe, and GLC63 AMG vehicles equipped with Audio 20 head units and automatic child seat recognition because the status of the passenger side airbag may not display correctly. The company cautions that if the passenger airbag is incorrectly displayed as "ON" when it is not, a front seat passenger may be unaware that the airbag will not deploy in the event of a crash, increasing their risk of injury (NHTSA Recall Notice, No. 18V838, Report receipt date: November 27, 2018).

Remedy. MBUSA will notify owners, and dealers will update the audio head unit software, free of charge. The recall is expected to begin January 2, 2019.

Contact information. Owners may contact MBUSA customer service at 1-800-367-6372. Owners may also contact the National Highway Traffic Safety Administration Vehicle Safety Hotline at 1-888-327-4236 (TTY 1-800-424-9153), or go to www.safercar.gov.

Companies: Mercedes-Benz USA, LLC

MainStory: TopStory RecallNewsStory MotorVehiclesNews

Back to Top

Interested in submitting an article?

Submit your information to us today!

Learn More
Reading Products Liability Law Daily on phone

Product Liability Law Daily: Breaking legal news at your fingertips

Sign up today for your free trial to this daily reporting service created by attorneys, for attorneys. Stay up to date on product liability legal matters with same-day coverage of breaking news, court decisions, legislation, and regulatory activity with easy access through email or mobile app.

Free Trial Learn More